Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Date:7/14/2009

vituximab toward later-stage clinical trials. Planning for this exciting next phase for our bavituximab oncology program has already begun."

Mr. King added, "This past year we also made significant advancements in our bavituximab and broader anti-PS anti-viral program, receiving high-profile international validation through the publication of data in the highly respected scientific journal Nature Medicine, which confirmed the anti-viral potential of bavituximab and our other anti-PS antibodies. We were also successful in completing contract negotiations with the DTRA, allowing us to expand the evaluation of our anti-PS antibodies as potential broad spectrum agents for the treatment or prevention of viral hemorrhagic fever virus infections. This contract directly or indirectly supports our bavituximab and other anti-PS technology programs and represents another significant validation for the anti-PS technology platform."

Mr. King continued, "Our Cotara clinical program continues to advance with patient enrollment nearing completion in our dose confirmation and dosimetry study in patients with recurrent glioblastoma (GBM), and enrollment exceeds the halfway mark in our Phase II trial in relapsed GBM patients. We recently presented dosimetry study data at the Society of Nuclear Medicine 2009 Annual Meeting, further confirming that Cotara specifically localizes to brain tumors at high concentrations with minimal radiation exposure to other organs, reinforcing its potential as a possible new treatment for GBM."

At April 30, 2009, Peregrine had $10 million in cash and cash equivalents, compared to $15.1 million in cash and cash equivalents at April 30, 2008. After the close of the 2009 fiscal year, Peregrine raised approximately $6.9 million in gross proceeds from the sale of common stock from its existing shelf registration. The stock was sold in an "At the Market" offering as defined in Rule 415
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... would have really been in trouble, expert says , , ... the pandemic H1N1 swine flu has revealed serious flaws ... emergencies, a new report says. , The report, prepared ... Wood Johnson Foundation, also finds the dire economy has ... 2009 H1N1 outbreak is the latest in a series ...
(Date:12/15/2009)... not delivered ,, WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ ... ensure that healthcare reform does not override the ... companies in 37 states. ,, Prostate cancer screening ... population and individuals who are identifiable as high ... have a family history of prostate cancer. The ...
(Date:12/15/2009)... -- 4R Systems, Inc., a leading provider of ... retailers significantly increase profits by optimizing their inventory ... The Vitamin Shoppe has been utilizing the 4R ... DC inventory solutions have helped us drive significant ... the last two years," said Tony Truesdale, President ...
(Date:12/15/2009)... --The following are the remarks by Lanny ... division, at the Medicare Fraud Strike Force press ... you for the enormous effort everyone at HHS ... Together, our Departments have and will continue to ... tremendous progress in fighting Medicare fraud in South ...
(Date:12/15/2009)... Continuing Strike Force Operations Lead to Indictment of ... with more than $61 Million in Fraudulent Billing ... Thirty people have been charged in ... to submit more than $61 million in false ... of the Medicare Fraud Strike Force, Department of ...
Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5
... A new study has found that a compound from olive-pomace ... ,Researchers from the University of Granada and Hospital Carlos ... from olive skin, inhibits serin-protease, the enzyme used by HIV ... cellular environment and, subsequently, to spread the infection into the ...
... the University of Texas M. D. Anderson Cancer Center ... therapy selectively embeds a gene in pancreatic cancer ... survival virtually without toxicity. ,"This vehicle, ... cancer-specific expression that it can be used for therapy ...
... from Cushings Syndrome can breathe a bit easily now. ... orphan drug status for its Corlux from the Food ... a disorder caused by prolonged exposure of the body's ... , ,Symptoms vary, but most people have high ...
... who smoke, may be at an increased risk of respiratory ... balanced diet . ,The finding comes from a ... Public Health, Health Canada, Brigham and Women's Hospital, and the ... School of Public Health who found that teens whose diet ...
... at The University of Nottingham have just given people another ... more muscle mass in old age than non-smokers . ... posed by smoking such as cancer, heart attacks and strokes. ... to have a lower muscle mass than non-smokers, for the ...
... Duke University has created high resolution, three-dimentional microscopic images ... of the organ. ,The researchers could ... magnetic resonance imaging. ,"These images can ... clinical MRI scan," said G. Allan Johnson, Duke's Charles ...
Other Medicine News:Health News:Gene Therapy Eradicates Pancreatic Cancer in Mice 2Health News:FDAs Gesture for Firm Manufacturing Drug for Cushings Syndrome 2Health News:A Balanced Diet can Keep Asthma, Wheezing at Bay in Teens 2Health News:Smoking Speeds Up Muscle Loss 2Health News:Now, 'virtual' Mouse Brains Available on the Net 2
(Date:12/15/2009)... Varian Medical Systems (NYSE: VAR ... first quarter of fiscal year 2010 following the close ... The news release will be followed by a teleconference ... The news release and a link to the ... website at: www.varian.com/investor . To access the ...
(Date:12/15/2009)... Dec. 15 Vivakor, Inc. (OTC ... divisions have reported strong performance in 2009. ... and development with divisional spokes developing multiple ... Product Pipeline strategy is anchored to the ... idea inception, Vivakor,s R&D efforts target commercialization ...
(Date:12/15/2009)... -- Estill Medical Technologies, Inc., a family-owned Texas company ... Fluid Infusion Warmer , a patented medical device being ... and emergency responders to lessen the effects ... Unit of South Lake Tahoe as the first-ever recipient ... ,, CALSTAR is a California-based nonprofit emergency ...
Breaking Medicine Technology:Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Vivakor Divisions Continue to Demonstrate Independent Growth 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males 12882 1Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males 12882 2American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients 3B Organizing Doctors to Oppose Government Run Hea 50645 1American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients 3B Organizing Doctors to Oppose Government Run Hea 50645 2News media registration open for 20th World Diabetes Congress 50640 1
... IntertwinedROCHESTER, Minn., Feb. 4 Here are highlights from ... . You may cite this publication as often as ... attribution is required. Reprinting is allowed ... your editorial policies permit: Visit www.bookstore.mayoclinic.com or ...
... (OTCBB: ORMP.OB), a developer of alternative drug,delivery systems, ... of concept,study in South Africa of insulin suppositories, ... for two visits, with,two different formulations. , ... insulin absorption and reactive,glucose lowering effect. The suppositories ...
Other Medicine Technology:February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 2February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 3February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 4February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 5Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
... BacT/Alert 3D Signature is a state ... system that integrates blood, sterile body ... a powerful microbiology workstation with comprehensive ... volume identification and where expanded flexibility ...
... automated instrument that offers Rapid results (with ... same day turnaround), random or batch processing ... used for bacterial and yeast identification, antimicrobial ... a complete data management system. It processes ...
IDS Rapid One, a microbial identification system....
Medicine Products: